Improve daily functioning through teams
- Trial ID
- NCT05433441
- Official Title
- Evaluation of the Effectiveness of the Parkinson's Specialized Teams Intervention on the Quality of Life of Parkinson's Patients in the Territory of the Nouvelle-Aquitaine and Hauts-de-France: ES-Park Pilot Study.
- Goal
- Improve daily functioning through teams
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University Hospital, Bordeaux
- Study Type
- INTERVENTIONAL
- Enrollment
- 250 participants
- Conditions
- Parkinson Disease
- Interventions
- ESPark Intervention
Plain-Language Summary
The trial is testing whether specialized, multidisciplinary Parkinson's teams can improve quality of life for people with more advanced Parkinson's in the Nouvelle-Aquitaine and Hauts-de-France regions. The teams deliver coordinated, individualized care such as medication review, tailored physical and occupational therapy plans, home-based support and caregiver education, aiming to reduce disability, falls and daily burden rather than testing a drug. They are enrolling adults with idiopathic Parkinson's who are Hoehn and Yahr stage 3 or higher, have no major cognitive impairment (MOCA ≥21), live at home and have a willing nonprofessional caregiver. Both patient and caregiver must consent and be able to complete follow-up interviews, while people with dementia, imminent institutionalization, severe unstable illness or participation in other non-drug management trials are excluded.
Locations
- Hopital Pellegrin, Bordeaux, France
- CHU de Lille, Lille, France
- CHU de Limoges, Limoges, France
- CHU Poitiers, Poitiers, France
Frequently Asked Questions
- What is this trial testing?
- This trial is studying ESPark Intervention. The trial is testing whether specialized, multidisciplinary Parkinson's teams can improve quality of life for people with more advanced Parkinson's in the Nouvelle-Aquitaine and Hauts-de-France regions. The teams deliver coordinated, individualized care such as medication review, tailored physical and occupational therapy plans, home-based support and caregiver education, aiming to reduce disability, falls and daily burden rather than testing a drug. They are enrolling adults with idiopathic Parkinson's who are Hoehn and Yahr stage 3 or higher, have no major cognitive impairment (MOCA ≥21), live at home and have a willing nonprofessional caregiver. Both patient and caregiver must consent and be able to complete follow-up interviews, while people with dementia, imminent institutionalization, severe unstable illness or participation in other non-drug management trials are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 4 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 3 years.